| 000 | 02113 a2200565 4500 | ||
|---|---|---|---|
| 005 | 20250518060227.0 | ||
| 264 | 0 | _c20210204 | |
| 008 | 202102s 0 0 eng d | ||
| 022 | _a1878-7479 | ||
| 024 | 7 |
_a10.1007/s13311-019-00773-w _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKamiński, Krzysztof | |
| 245 | 0 | 0 |
_aN-Benzyl-(2,5-dioxopyrrolidin-1-yl)propanamide (AS-1) with Hybrid Structure as a Candidate for a Broad-Spectrum Antiepileptic Drug. _h[electronic resource] |
| 260 |
_bNeurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics _c01 2020 |
||
| 300 |
_a309-328 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnticonvulsants _xadministration & dosage |
| 650 | 0 | 4 |
_aBehavior, Animal _xdrug effects |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aEpilepsy _xchemically induced |
| 650 | 0 | 4 |
_aEthosuximide _xchemistry |
| 650 | 0 | 4 |
_aLacosamide _xchemistry |
| 650 | 0 | 4 |
_aLevetiracetam _xchemistry |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aPentylenetetrazole _xadministration & dosage |
| 650 | 0 | 4 |
_aPyrrolidines _xadministration & dosage |
| 650 | 0 | 4 |
_aSeizures _xchemically induced |
| 650 | 0 | 4 |
_aValproic Acid _xadministration & dosage |
| 650 | 0 | 4 | _aZebrafish |
| 700 | 1 | _aSocała, Katarzyna | |
| 700 | 1 | _aZagaja, Mirosław | |
| 700 | 1 | _aAndres-Mach, Marta | |
| 700 | 1 | _aAbram, Michał | |
| 700 | 1 | _aJakubiec, Marcin | |
| 700 | 1 | _aPieróg, Mateusz | |
| 700 | 1 | _aNieoczym, Dorota | |
| 700 | 1 | _aRapacz, Anna | |
| 700 | 1 | _aGawel, Kinga | |
| 700 | 1 | _aEsguerra, Camila V | |
| 700 | 1 | _aLatacz, Gniewomir | |
| 700 | 1 | _aLubelska, Annamaria | |
| 700 | 1 | _aSzulczyk, Bartłomiej | |
| 700 | 1 | _aSzewczyk, Aleksandra | |
| 700 | 1 | _aŁuszczki, Jarogniew Jacek | |
| 700 | 1 | _aWlaź, Piotr | |
| 773 | 0 |
_tNeurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics _gvol. 17 _gno. 1 _gp. 309-328 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s13311-019-00773-w _zAvailable from publisher's website |
| 999 |
_c30077590 _d30077590 |
||